Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic
Preprint
Abstract
Background The global prevalence of PASC is estimated to be present in 0·43 and based on the WHO estimation of 470 million worldwide COVID-19 infections, corresponds to around 200 million people experiencing long COVID symptoms. Despite this, its clinical features are not well defined. Methods We collected retrospective data from 140 patients with PASC in a post-COVID-19 clinic on demographics, risk factors, illness severity (graded as one-mild to five-severe), functional status, and 29 symptoms and principal component symptoms cluster analysis. The Institute of Medicine (IOM) 2015 criteria were used to determine the ME/CFS phenotype. Findings The median age was 47 years, 59·0% were female; 49·3% White, 17·2% Hispanic, 14·9% Asian, and 6·7% Black. Only 12·7% required hospitalization. Seventy-two (53·5%) patients had no known comorbid conditions. Forty-five (33·9%) were significantly debilitated. The median duration of symptoms was 285·5 days, and the number of symptoms was 12. The most common symptoms were fatigue (86·5%), post-exertional malaise (82·8%), brain fog (81·2%), unrefreshing sleep (76·7%), and lethargy (74·6%). Forty-three percent fit the criteria for ME/CFS. Interpretations Most PASC patients evaluated at our clinic had no comorbid condition and were not hospitalized for acute COVID-19. One-third of patients experienced a severe decline in their functional status. About 43% had the ME/CFS subtype. Funding The study did not received funding.Keywords
All Related Versions
- Published version: Frontiers in Neurology, 14, 1090747.
This publication has 23 references indexed in Scilit:
- Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany – a first analysis of a prospective observational studymedRxiv, 2021
- Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global PandemicClinical Infectious Diseases, 2021
- Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormonesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2021
- Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic CollideMayo Clinic Proceedings, 2020
- Sex Differences in Mortality From COVID-19 PandemicJACC: Case Reports, 2020
- The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19European Respiratory Journal, 2020
- Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)Journal of Translational Medicine, 2020
- actuar: AnRPackage for Actuarial ScienceJournal of Statistical Software, 2008
- Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort studyBMJ, 2006